|
受注:045-509-1970 |
技術サポート:tech@selleck.co.jp 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
製品コード:A2305 Batch: A230501
Ranibizumab (Anti-VEGFA) is a recombinant humanized IgG1 monoclonal antibody fragment that inhibits (VEGF-A) and degrades angiogenesis throughout the body and in the eye also interrupts the interaction of VEGF with its receptors, and thus prevents the subsequent growth of new blood vessels.
| CAS No. | 347396-82-1 |
|---|---|
| Formulation | 100 mM Pro-Ac, 20mM Arg, pH5.0 |
| Isotype | Human IgG1 |
| Source | CHO |
| Storage (From the date of receipt) |
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles. |
| Shipping | Shipped under low temperature conditions |
| Purity | 99% |
| Protein concentration | 3.61mg/ml |
| Endotoxin Level | <1EU/mg |
| The role of vitamin K and its antagonist in the process of ferroptosis-damaged RPE-mediated CNV [ Cell Death Dis, 2025, 16(1):190] | PubMed: 40108164 |
人間や獣医の診断であるか治療的な使用のためにでない。